Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Neuregulin1-β Decreases IL-1β-Induced Neutrophil Adhesion to Human Brain Microvascular Endothelial Cells.
Utilization of brain MRI with focus on cerebral lesions and atrophy to better characterize MS phenotypes.
JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.
Anorexia heralding the onset of neuromyelitis optica.
CD5-positive B cell subsets in secondary progressive multiple sclerosis.
Identifying and treating pain caused by MS.
Distinguishing Susac's syndrome from multiple sclerosis.
Sleep and oligodendrocyte functions.
The radiologically isolated syndrome.
Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
Enigmatic GPCR Finds a Stimulating Drug.
Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis.
The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis.
[Levels of Beclin 1 and LC3 in peripheral blood mononuclear cells of patients with multiple sclerosis and neuromyelitis optica and its significance].
Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial
Immunomodulatory Effects of Histone Deacetylase Inhibitors.
Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination.
Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.
New methods for multiple sclerosis drug discovery.
Words: Perception, "-Omics" Another Epidemic? Vaccine Optic Neuritis; An Amblyopia Symposium; Strasbismus surgery anesthesia.
Cognition, mood, and purpose in life in neuromyelitis optica spectrum disorder.
dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis.
Autophagic myelin destruction by schwann cells during wallerian degeneration and segmental demyelination.
Pages
« first
‹ previous
…
267
268
269
270
271
272
273
274
275
…
next ›
last »